Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1Hypertension 1Hot Flashes 1Diabetes Mellitus 1Depressive Disorder, Major 1Depression 1Cardiovascular Diseases 1Breast Neoplasms 1

Interventions

Metformin 8Surveys and Questionnaires 3Pioglitazone 3Nutrition Assessment 3Methods 3Exercise 3Educational Status 3Tirzepatide 2Therapeutics 2Tablets 2Standard of Care 2Specimen Handling 2Resistance Training 2Interviews as Topic 2Glucose Tolerance Test 2Biopsy 2tocilizumab 1tislelizumab 1sofosbuvir-velpatasvir drug combination 1saxagliptin 1pembrolizumab 1otelixizumab 1nabiximols 1esmolol 1epalrestat 1donafenib 1dapagliflozin 1amlodipine, atorvastatin drug combination 1Verapamil 1Urine Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diabetes Mellitus × Desvenlafaxine Succinate × Clear all
NCT01803711 2017-12-27

Omega 3 FA Supplements as Augmentation in the Treatment of Depression

UConn Health

Phase 2/3 Terminated
6 enrolled 4 charts

Cardiovascular Diseases, Depression, Depressive Disorder, Major, Diabetes Mellitus, Hypertension, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡